Compare LABT & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LABT | HCTI |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 3.9M |
| IPO Year | N/A | 2021 |
| Metric | LABT | HCTI |
|---|---|---|
| Price | $2.56 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 276.0K | 74.7K |
| Earning Date | N/A | 04-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,891,000.00 |
| Revenue This Year | N/A | $79.33 |
| Revenue Next Year | N/A | $20.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.77 |
| 52 Week Low | $2.10 | $0.01 |
| 52 Week High | $4.72 | $20.42 |
| Indicator | LABT | HCTI |
|---|---|---|
| Relative Strength Index (RSI) | 31.54 | 39.30 |
| Support Level | $2.10 | $1.70 |
| Resistance Level | N/A | $2.57 |
| Average True Range (ATR) | 0.61 | 0.17 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 19.85 | 12.31 |
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.